ibuprofen, (r)-isomer has been researched along with repaglinide in 1 studies
| Studies (ibuprofen, (r)-isomer) | Trials (ibuprofen, (r)-isomer) | Recent Studies (post-2010) (ibuprofen, (r)-isomer) | Studies (repaglinide) | Trials (repaglinide) | Recent Studies (post-2010) (repaglinide) |
|---|---|---|---|---|---|
| 10 | 0 | 4 | 610 | 152 | 244 |
| Protein | Taxonomy | ibuprofen, (r)-isomer (IC50) | repaglinide (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 9.2 | |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | 9.2 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
1 other study(ies) available for ibuprofen, (r)-isomer and repaglinide
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |